

HY-P5005 · 5 mg
MedChemExpress · Cat: HY-P5005
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/viphyb.htmlDescription
VIPhyb is a vasoactive intestinal polypeptide VIP receptor antagonist. VIPhyb can inhibit VIP signaling, increase T-cell immunity and downregulate PD1. VIPhyb can inhibit cancer cell proliferation. VIPhyb can reduce inflammatory cytokine expression. VIPhyb can enhance viral clearance. VIPhyb can be used for the researches of cancer, infection and inflammation and immunology, such as non-small cell lung cancer NSCLC , cytomegalovirus infection and colitis.



